Gastrointestinal Drugs Market to Grow at 4.90% CAGR by 2024, due to Growing Investment for Development of Novel Drugs, TMR Observes

valued at US$45.5 bn in 2015 and expected to reach the value of US$61.6 bn by the end of 2024 by expanding with the CAGR of 4.90% over the forecast years from 2016 to 2024. Based on the drug

class, the gastrointestinal drugs market is dominated by the acid neutralizers and expected to remain dominant over the forecast period. Based on the region, the global market for gastrointestinal drugs dominated by North America with 41% shares in 2016 and expected to remain dominant by the end of predicted years. However, Asia Pacific is expected to grow with faster CAGR over the forecast period.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20987

Rising Government Initiatives and Investment to Boost Growth

According to the World Gastroenterology Organization, 15 to 25% of the people globally are suffering from gastro-esophageal reflux disease (GERD). This is a key factor in boosting the need for the gastrointestinal drugs and likely to propel the growth of the global gastrointestinal drugs market. Growing awareness about the disease and increasing availability of treatments is boosting adoption of the gastrointestinal drugs and likely to fuel the growth of the global gastrointestinal drugs market. Additionally, growing investments in research and development (R&D) activities for the development of novel drugs are further expected to fuel the growth of the global gastrointestinal drugs market.

Request a Custom Report at
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=20987

Moreover, growing geriatric population in the emerging economies is leading to surg the number of the patients suffering from gastrointestinal diseases which are further fuelling the growth of the global gastrointestinal drugs market. In addition, numerous initiatives are taken by the Centers for Disease Control and Prevention (CDC) in order to promote cancer screening globally is fuelling the growth of the gastrointestinal drugs market. Also, The Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign (NCCCP) are increasingly providing funds for research studies. The development and launch of the new improved products are fuelling growth of the global gastrointestinal drugs market.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20987

Lack of Novel Drugs for Treatment to Restrain Growth

Despite these growth possibilities, lack of a permanent cure for gastrointestinal diseases is posing as a challenge to the growth of the global gastrointestinal drugs market. Additionally, etiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are limiting growth of the global market. Nevertheless, the consistent technological advancements due to higher investment in the research and development (R&D) activities for development activities of treatment therapies of gastrointestinal diseases are projected to create lucrative opportunities for growth over the forecast period.

Request for Discount on This Report at
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=20987

The global gastrointestinal drugs market has a strongly consolidated vendor landscape, observes Transparency Market Research (TMR). Top three players operating in the gastrointestinal drugs market such as Valeant Pharmaceuticals Inc., Janssen Biotech Inc., and Takeda Pharmaceutical collectively accounted for 61% in 2016. Some of the other players operating in the global gastrointestinal drugs market are Abbott Laboratories, Allergan Plc, AstraZeneca, Bayer AG, and Boehringer Ingelheim GmbH. The market is moderately competitive for now but, the degree of competition is expected to increase over the forecast period.

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer